| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,137 |
14,844 |
$1.01M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,001 |
19,429 |
$928K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
7,968 |
7,726 |
$254K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,402 |
2,326 |
$195K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,369 |
2,295 |
$155K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,730 |
2,445 |
$154K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,270 |
8,929 |
$119K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,390 |
4,232 |
$75K |
| X5622 |
|
2,393 |
2,339 |
$59K |
| 36415 |
Collection of venous blood by venipuncture |
16,863 |
14,997 |
$51K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
724 |
706 |
$48K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,699 |
1,646 |
$41K |
| 99188 |
|
3,538 |
3,437 |
$27K |
| 92551 |
|
2,404 |
2,329 |
$14K |
| 90686 |
|
2,874 |
2,793 |
$13K |
| 96127 |
|
3,459 |
3,239 |
$12K |
| 85027 |
|
2,353 |
2,203 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
828 |
799 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,390 |
1,146 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
137 |
133 |
$9K |
| 0012A |
|
407 |
398 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
465 |
448 |
$8K |
| 80061 |
Lipid panel |
732 |
701 |
$8K |
| 0011A |
|
427 |
415 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
209 |
204 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,003 |
911 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
178 |
175 |
$6K |
| 80053 |
Comprehensive metabolic panel |
584 |
544 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
146 |
144 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
631 |
606 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
763 |
722 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
726 |
677 |
$5K |
| S0280 |
Medical home program, comprehensive care coordination and planning, initial plan |
17 |
13 |
$4K |
| 99173 |
|
2,472 |
2,397 |
$3K |
| 99442 |
|
116 |
77 |
$3K |
| 90715 |
|
221 |
212 |
$3K |
| 99000 |
|
210 |
196 |
$2K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
88 |
88 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
240 |
185 |
$2K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22 |
21 |
$2K |
| 99441 |
|
137 |
85 |
$2K |
| 99421 |
|
87 |
82 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
55 |
53 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
74 |
73 |
$1K |
| 90670 |
|
1,266 |
1,223 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
49 |
49 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
27 |
25 |
$1K |
| 86780 |
|
86 |
86 |
$1K |
| 81025 |
|
134 |
131 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$1K |
| 81001 |
|
418 |
406 |
$994.13 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
41 |
39 |
$978.47 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
26 |
26 |
$955.75 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
43 |
40 |
$943.75 |
| 86803 |
|
59 |
59 |
$894.29 |
| 99443 |
|
16 |
13 |
$800.47 |
| 90682 |
|
27 |
27 |
$745.82 |
| 85610 |
|
249 |
157 |
$721.31 |
| 90474 |
|
66 |
65 |
$666.63 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$626.76 |
| 87210 |
|
117 |
113 |
$582.72 |
| 90651 |
|
48 |
48 |
$555.64 |
| 90473 |
|
36 |
36 |
$527.01 |
| 36416 |
|
136 |
99 |
$380.57 |
| 96161 |
|
185 |
178 |
$338.85 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
40 |
39 |
$334.02 |
| 0064A |
|
18 |
17 |
$314.08 |
| 87081 |
|
144 |
129 |
$282.32 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
16 |
14 |
$251.75 |
| 84439 |
|
26 |
24 |
$220.75 |
| 90707 |
|
13 |
13 |
$162.26 |
| 90734 |
|
64 |
61 |
$131.10 |
| 90656 |
|
55 |
54 |
$118.33 |
| 90685 |
|
178 |
152 |
$87.96 |
| 0002A |
|
61 |
46 |
$83.91 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
61 |
59 |
$74.19 |
| 82950 |
|
12 |
12 |
$62.04 |
| 0001A |
|
14 |
13 |
$55.92 |
| G0008 |
Administration of influenza virus vaccine |
139 |
139 |
$50.78 |
| 86140 |
|
14 |
13 |
$48.25 |
| 85018 |
|
20 |
12 |
$39.90 |
| 85652 |
|
15 |
13 |
$24.97 |
| 90633 |
|
319 |
308 |
$7.56 |
| 90698 |
|
674 |
644 |
$0.15 |
| 90680 |
|
116 |
115 |
$0.00 |
| 90744 |
|
181 |
174 |
$0.00 |
| 99243 |
|
54 |
53 |
$0.00 |
| 90696 |
|
24 |
24 |
$0.00 |
| 90681 |
|
53 |
51 |
$0.00 |
| 90710 |
|
24 |
24 |
$0.00 |
| 11100 |
|
17 |
12 |
$0.00 |
| 90700 |
|
12 |
12 |
$0.00 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
27 |
26 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
17 |
16 |
$0.00 |